- Nasdaq goes back to red after gaining at the opening
- Oracle’s shares fall on estimates miss and weak guidance
- US job openings up in January
The performance of major U.S. continues on a bad steak. Following its biggest selloff since 2022, the tech-heavy Nasdaq attempted to rebound at the session’s open but is currently down 0.6%. Both the DJIA and S&P 500 are extending losses (-1% and -0.4%, respectively), while the small-cap Russell 2000 adds 0.1%.
The JOLTS report exceeded expectations, showing 7.74 million new job openings in the U.S. versus the 7.6 million estimate (previous: 7.5 million). The EUR/USD rally slowed following the report, easing concerns raised by last week’s slightly underwhelming ADP and NFP data. However, recent ISM surveys suggest that labor demand is already fading. Market conditions continue to moderate amid uncertainty over Trump’s trade policy and its potential impact on U.S. business activity.
Volatility currently observed on Wall Street. Source: xStation5
US100 (D1)
The contract for Nasdaq 100 index is attempting a recovery after a streak of consecutive losses and yesterday’s selloff. The RSI indicates an overselling of US100, motivating a potential bullish pullback. Nevertheless, the US100 is still rather undecided, hovering around 0, as Magnificent 7 stocks drag the index in the opposite directions (Tesla: +3.5%, Nvidia: +1.6%, Apple: -1.9%, Alphabet: -0.5%).
Source: xStation5
Corporate news:
- 2Seventy Bio shares surged 77% after Bristol Myers Squibb agreed to acquire the company for $5 per share, a 78.6% premium to its last close. The $286M deal is expected to close in Q2, with shares delisting from Nasdaq post-merger. 2Seventy Bio focuses on developing cancer cell therapies, including Abecma, a CAR-T therapy for multiple myeloma, co-developed with BMY.
- American Airlines’ (AAL.US) shares fell 5.5% after doubling its expected Q1 loss to up to $0.80 per share (previously $0.40). Revenue is now projected to be flat vs. prior 5% growth forecast, citing weaker demand and fallout from recent aviation incidents.
- Delta Air Lines’ (DAL.US) shares fell 7.5% after slashing Q1 profit guidance to $0.30-$0.50 per share (previously $0.70-$1.00). Revenue growth outlook dropped to 3%-4% from 7%-9%. Weaker consumer and corporate demand hit domestic travel, pressuring the sector.
- Oracle (ORCL.US) shares fell 6.6% after missing Q3 revenue estimates ($14.1B vs. $14.4B expected) and issuing weak guidance. Cloud revenue rose 23% to $6.2B but missed forecasts. FY26 sales are expected to grow 15%, driven by AI infrastructure and major cloud deals.
The material on this page does not constitute financial advice and does not take into account your level of understanding, investment objectives, financial situation or any other specific needs. All information provided, including opinions, market research, mathematical results and technical analyzes published on the Website or transmitted To you by other means, it is provided for information purposes only and should in no way be construed as an offer or solicitation for a transaction in any financial instrument, nor should the information provided be construed as advice of a legal or financial nature on which any investment decisions you make should be based exclusively To your level of understanding, investment objectives, financial situation, or other specific needs, any decision to act on the information published on the Website or sent to you by other means is entirely at your own risk if you In doubt or unsure about your understanding of a particular product, instrument, service or transaction, you should seek professional or legal advice before trading. Investing in CFDs carries a high level of risk, as they are leveraged products and have small movements Often the market can result in much larger movements in the value of your investment, and this can work against you or in your favor. Please ensure you fully understand the risks involved, taking into account investments objectives and level of experience, before trading and, if necessary, seek independent advice.
